| 000 | 01511 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513191035.0 | ||
| 264 | 0 | _c19990902 | |
| 008 | 199909s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm9902279 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBom, D | |
| 245 | 0 | 0 |
_aNovel A,B,E-ring-modified camptothecins displaying high lipophilicity and markedly improved human blood stabilities. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cAug 1999 |
||
| 300 |
_a3018-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aCamptothecin _xanalogs & derivatives |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 |
_aDimyristoylphosphatidylcholine _xchemistry |
| 650 | 0 | 4 | _aDrug Stability |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xchemical synthesis |
| 650 | 0 | 4 | _aFluorescence Polarization |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrolysis |
| 650 | 0 | 4 |
_aPhosphatidylglycerols _xchemistry |
| 650 | 0 | 4 | _aSpectrometry, Fluorescence |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 | _aTopoisomerase I Inhibitors |
| 700 | 1 | _aCurran, D P | |
| 700 | 1 | _aChavan, A J | |
| 700 | 1 | _aKruszewski, S | |
| 700 | 1 | _aZimmer, S G | |
| 700 | 1 | _aFraley, K A | |
| 700 | 1 | _aBurke, T G | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 42 _gno. 16 _gp. 3018-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm9902279 _zAvailable from publisher's website |
| 999 |
_c10405666 _d10405666 |
||